Health Catalyst shareholders reject advisory vote on executive compensation at 2022 annual meeting

Health Catalyst, Inc.

Say-on-pay proposal received 20,019,370 for, 23,100,748 against, 46,068 abstain, 3,010,476 broker non-votes.
Both Class III director nominees elected: Duncan Gallagher (28,400,049 for, 14,766,137 withheld) and Mark B. Templeton (33,605,452 for, 9,560,734 withheld).
Ratification of Ernst & Young as auditor for FY2022 passed: 45,758,062 for, 378,823 against, 39,777 abstain.
Total shares present at meeting: 46,176,662 of 53,937,142 entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.